<html>
<head>PUBMED IDs for MHS1</head>
<body bgcolor='#C5F0F2'><h1>MHS1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/1427885/'>Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q.</a> November 1  1992<br><a href='https://pubmed.ncbi.nlm.nih.gov/7887423/'>Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1.</a> March 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/7762556/'>Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene.</a> June 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/10931834/'>NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.</a> August 10  2000<br></body></html>
